J&J to pump another $13B into its MedTech business with Shockwave deal
Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles
Independent UN experts urge Yemen’s Houthis to free detained Baha'i followers
CAIRO (AP) — Human rights experts working for the United Nations on Monday urged Yemen’s Houthi rebe2024-05-21Plan to tap Russian assets for Ukraine slammed
The Russian flag flies on the dome of the Kremlin Senate building behind Spasskaya Tower, in central2024-05-21One year of war in Sudan, thousands killed, millions displaced amid imminent famine
KHARTOUM, April 14 (Xinhua) -- The deadly war in Sudan, leaving thousands of people dead and million2024-05-21Interview: Nigeria would learn from Chinese model of development
ABUJA, May 2 (Xinhua) -- The Nigerian government is showing keen interest in studying the Chinese mo2024-05-21'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
CHICAGO (AP) — The road for Shota Imanaga from Japan to the major leagues included at least one shar2024-05-21Xi chairs CPC leadership meeting to review reports, guideline and regulations
The Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on Jan.2024-05-21
atest comment